Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Neovascularisation”

277 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 277 results

Post-approval studies (Phase 4)Ended earlyNCT00327470
What this trial is testing

An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD

Who this might be right for
Age Related Macular Degeneration (AMD)Macular DegenerationChoroidal Neovascularization (CNV)
Pfizer 288
Large-scale testing (Phase 3)Study completedNCT00021736
What this trial is testing

Phase II/III Study of Anti-VEGF in Neovascular AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Eyetech Pharmaceuticals 540
Not applicableStudy completedNCT00358345
What this trial is testing

PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 347
Testing effectiveness (Phase 2)Ended earlyNCT00090532
What this trial is testing

The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Pfizer 155
Early research (Phase 1)Study completedNCT00457145
What this trial is testing

Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation

Who this might be right for
Telangiectasia
National Eye Institute (NEI) 5
Large-scale testing (Phase 3)Study completedNCT03823287
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Who this might be right for
Wet Macular Degeneration
Hoffmann-La Roche 671
Early research (Phase 1)UnknownNCT00767949
What this trial is testing

Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Lpath, Inc. 15
Large-scale testing (Phase 3)Study completedNCT00090623
What this trial is testing

RhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Genentech, Inc. 180
Early research (Phase 1)Study completedNCT00685503
What this trial is testing

Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth

Who this might be right for
Neovascularization
National Eye Institute (NEI) 1
Not applicableUnknownNCT03838679
What this trial is testing

Imaging of the Angiofibrotic Switch in Neovascular AMD

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Medical University of Vienna 120
Testing effectiveness (Phase 2)Study completedNCT01136252
What this trial is testing

Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Hospital Universitari Vall d'Hebron Research Institute 5
Large-scale testing (Phase 3)Study completedNCT00058994
What this trial is testing

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

Who this might be right for
Macular DegenerationMaculopathy, Age-Related
Alcon Research
Not applicableLooking for participantsNCT07235527
What this trial is testing

Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationExudative Age-Related Macular DegenerationAnti Vascular Endothelial Growth Factor
Saglik Bilimleri Universitesi 54
Testing effectiveness (Phase 2)Study completedNCT01162746
What this trial is testing

Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationNeovascularization, Choroidal
Medical University of Vienna 40
Post-approval studies (Phase 4)UnknownNCT03211741
What this trial is testing

Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema

Who this might be right for
Retinal NeovascularizationMacular Edema
University Hospital, Ghent 500
Large-scale testing (Phase 3)Study completedNCT04239027
What this trial is testing

Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Novartis Pharmaceuticals 210
Not applicableUnknownNCT01521819
What this trial is testing

Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

Who this might be right for
Retinal Pigment Epithelial Detachment With VascularizationAge Related Macular Degeneration
Oraya Therapeutics, Inc. 12
Not applicableLooking for participantsNCT04985487
What this trial is testing

Regulatory Post-Marketing Surveillance Study for Brolucizumab

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 3,000
Testing effectiveness (Phase 2)Ended earlyNCT00333476
What this trial is testing

MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Genaera Corporation 140
Early research (Phase 1)Study completedNCT01255462
What this trial is testing

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Advanced Age-related Macular Degeneration
Novartis Pharmaceuticals 24
Load More Results